Literature DB >> 28267881

Distinctive role of efferocytosis in dendritic cell maturation and migration in sterile or infectious conditions.

Letícia de Aquino Penteado1, Naiara Naiana Dejani1,2, Felipe Fortino Verdan1,2, Allan Botinhon Orlando1, Victoria Eugenia Niño1, Fernanda De Nuzzi Dias1, Ana Carolina Guerta Salina1,2, Alexandra Ivo Medeiros1.   

Abstract

Efferocytosis, or clearance of apoptotic cells (ACs), by dendritic cells (DCs) leads to immune response suppression and tolerance to self-antigens. However, efferocytosis of infected apoptotic cells (IACs) leads to the production of a mixed pro- and anti-inflammatory cytokine milieu. We examined the DC phenotype and ability to migrate after phagocytosis of ACs or IACs and observed higher levels of CD86 and CCR7 expression in DCs, as well as enhanced migration capacity following efferocytosis of IACs. Interestingly, higher levels of interleukin-1β, interleukin-10 and prostaglandin E2 (PGE2 ) were also produced in this context. Blockage of IAC recognition led to an impaired maturation profile and PGE2 production, which may have contributed to reduced CD86 and CCR7 expression and migration capacity. These data contribute to the understanding of how efferocytosis of sterile or infected cells may regulate the adaptive immune response, although the precise role of PGE2 in this process requires further investigation.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  CCR7; dendritic cells; efferocytosis; infected apoptotic cell; prostaglandin E2

Mesh:

Substances:

Year:  2017        PMID: 28267881      PMCID: PMC5461093          DOI: 10.1111/imm.12731

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  48 in total

Review 1.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 2.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

Review 4.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels.

Authors:  Gwendalyn J Randolph; Veronique Angeli; Melody A Swartz
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

5.  An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo.

Authors:  Manikandan Subramanian; Crystal D Hayes; Joseph J Thome; Edward Thorp; Glenn K Matsushima; Joachim Herz; Donna L Farber; Kang Liu; Madepalli Lakshmana; Ira Tabas
Journal:  J Clin Invest       Date:  2014-02-10       Impact factor: 14.808

6.  Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells.

Authors:  Patricia A Valdez; Paul J Vithayathil; Brian M Janelsins; Arthur L Shaffer; Peter R Williamson; Sandip K Datta
Journal:  Immunity       Date:  2012-03-29       Impact factor: 31.745

7.  Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells.

Authors:  Elke Scandella; Ying Men; Silke Gillessen; Reinhold Förster; Marcus Groettrup
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

8.  Efferocytosis is an innate antibacterial mechanism.

Authors:  Constance J Martin; Matthew G Booty; Tracy R Rosebrock; Cláudio Nunes-Alves; Danielle M Desjardins; Iris Keren; Sarah M Fortune; Heinz G Remold; Samuel M Behar
Journal:  Cell Host Microbe       Date:  2012-09-13       Impact factor: 21.023

9.  Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling.

Authors:  Katia Boniface; Kristian S Bak-Jensen; Ying Li; Wendy M Blumenschein; Mandy J McGeachy; Terrill K McClanahan; Brent S McKenzie; Robert A Kastelein; Daniel J Cua; René de Waal Malefyt
Journal:  J Exp Med       Date:  2009-03-09       Impact factor: 14.307

10.  Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling.

Authors:  Alexandra I Medeiros; Carlos H Serezani; Sang Pyo Lee; Marc Peters-Golden
Journal:  J Exp Med       Date:  2009-01-05       Impact factor: 14.307

View more
  8 in total

Review 1.  Inflammasomes and adaptive immune responses.

Authors:  Katherine A Deets; Russell E Vance
Journal:  Nat Immunol       Date:  2021-02-18       Impact factor: 25.606

2.  Intestinal host defense outcome is dictated by PGE2 production during efferocytosis of infected cells.

Authors:  Naiara Naiana Dejani; Allan Botinhon Orlando; Victoria Eugenia Niño; Letícia de Aquino Penteado; Felipe Fortino Verdan; Júlia Miranda Ribeiro Bazzano; Ana Campos Codo; Ana Carolina Guerta Salina; Amanda Correia Saraiva; Matheus Rossi Avelar; Luis Carlos Spolidorio; C Henrique Serezani; Alexandra Ivo Medeiros
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

Review 3.  Efferocytosis in health and disease.

Authors:  Amanda C Doran; Arif Yurdagul; Ira Tabas
Journal:  Nat Rev Immunol       Date:  2019-12-10       Impact factor: 53.106

Review 4.  Rab GTPases in the differential processing of phagocytosed pathogens versus efferocytosed apoptotic cells.

Authors:  Nima Taefehshokr; Charles Yin; Bryan Heit
Journal:  Histol Histopathol       Date:  2020-09-29       Impact factor: 2.303

Review 5.  The immune response to secondary necrotic cells.

Authors:  Monika Sachet; Ying Yu Liang; Rudolf Oehler
Journal:  Apoptosis       Date:  2017-10       Impact factor: 4.677

Review 6.  Efferocytosis of Pathogen-Infected Cells.

Authors:  Niloofar Karaji; Quentin J Sattentau
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

7.  Inhibition of inflammasome activation by a clinical strain of Klebsiella pneumoniae impairs efferocytosis and leads to bacterial dissemination.

Authors:  Ana Campos Codo; Amanda Correia Saraiva; Leonardo Lima Dos Santos; Marina Francisco Visconde; Ana Cristina Gales; Dario Simões Zamboni; Alexandra Ivo Medeiros
Journal:  Cell Death Dis       Date:  2018-12-05       Impact factor: 8.469

Review 8.  Efferocytosis and Its Role in Inflammatory Disorders.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Front Cell Dev Biol       Date:  2022-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.